The Biden administration released its list of 10 drugs for direct price negotiations with manufacturers. The highly anticipated list is the most recent step in enacting a part of the Inflation Reduction Act (IRA) of 2022. The drugs listed are largely treatments related to Type 2 diabetes, blood thinning, arthritis and cancer...
On Wednesday, the U.S. Department of Health and Human Services announced its timeline for the Medicare Drug Price Negotiation Program, a key point of legislation in the Inflation Reduction Act (IRA).
In a press call, Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure said that the department will...
The pharmacy and benefits manager and provider (PBM) Optum, a subsidiary of UnitedHealth Group, helped to push growth expectations bringing UnitedHealthcare (UHC) net earnings outlook to $20.45 to $20.95 per share and adjusted net earnings to $21.40 to $21.90 per share. UnitedHealth Group reported revenues of $80.3 billion, demonstrating...National News
The new model tests a plan design that provides beneficiaries in participating plans with predictable copays for a broad set of formulary insulins, including rapid-acting, short-acting, intermediate-acting, and long-acting insulins, marketed by participating manufacturers; Sanofi, Novo Nordisk and Eli Lilli will collaborate or take...
